Search results
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 7 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
Are We Closer to a Cure for Diabetes? - Slashdot
Slashdot· 4 days agoThe researchers' results were published earlier in May in Cell Discovery, and are now getting some serious scrutiny from the press. The Economic Times cites a University of ...
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health...
Morningstar· 7 hours agoSeres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science ...
Retired shipyard designer waits for lifeline
WAVY via Yahoo News· 3 days agoPORTSMOUTH, Va. (WAVY) — Over the years, Newport News Shipbuilding senior designer John Slade Jr. was on hand for the commissionings and the overhauls of...
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 21 hours agoJeana Moore, 71, is not singing “I’m Gonna Be,” but she is walking hundreds of miles, thousands one...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both transplant...
Valley City Times Record· 3 days agoThe rates of deep and sustained MRD negativity were associated with improved progression-free...
Greeley girl fights rare, life-threatening blood disorder with positive attitude, deep bonds with...
Greeley Tribune· 5 days agoAubrie Dawson experienced a roller coaster of health scares that put her in a lot of...
HIV/AIDS Fast Facts – KION546
KION 46 Salinas· 23 hours agoAcute infection, or acute retroviral syndrome, which can produce flu-like symptoms in the first month after infection. Clinical latency, or asymptomatic...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 5 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 7 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting